Aperiam Bio
Latest round
- Seed
Last raised
- Sep 2023
Total raised
- $4M
Investors
- 4
About Aperiam Bio
Based in New York, US, and founded by Austin Cole (CEO) in 2021, Aperiam Bio, Inc. operates as a protein engineering company. The company engineers hyperfolding variants of protein, with improvements in expression, solubility, and specific activity. Aperiam's high-performing products span technical reagents, cosmetics, and pulmonary biologics. By identifying stabilizing mutations and creating shelf-stable enzymes, the company addresses challenges in manufacturing, consumer cosmetics, and therapeutic applications.
Who invested in Aperiam Bio
4 investors across 1 round
See all investors in Aperiam Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 18, 2023
Amount
$4M
Investors
Questions about Aperiam Bio
Who invested in Aperiam Bio?
Aperiam Bio has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aperiam Bio raised?
Aperiam Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Aperiam Bio last raise money?
Aperiam Bio's most recent round on record is a Seed, in Sep 2023.
What does Aperiam Bio do?
Based in New York, US, and founded by Austin Cole (CEO) in 2021, Aperiam Bio, Inc.
Where is Aperiam Bio headquartered?
Aperiam Bio is headquartered in New York, US.
Which VCs invest in companies like Aperiam Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back business support services companies at Aperiam Bio's stage. Their profiles are linked below.
VCs backing business support services startups at Seed
Raising like Aperiam Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.